Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 152.63B, Pfizer(PFE) trades at $26.85. The stock has a price-to-earnings ratio of 19.69 and currently yields dividends of 6.4%.
During the trading session on 2026-02-05, Pfizer(PFE) shares reached a daily high of $27.19 and a low of $26.52. At a current price of $26.85, the stock is +1.2% higher than the low and still -1.3% under the high.
Trading volume for Pfizer(PFE) stock has reached 21.78M, versus its average volume of 58.04M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
PFE News
Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can. Eli Lilly's (LLY +10.33%) obesity drug, Zepbound, generated sales of $13.5 billion i...
Pfizer (NYSE:PFE) reported statistically significant weight loss results from its Phase 2b VESPER-3 trial for a monthly injectable GLP-1 obesity drug. The cand...
Key Points Eli Lilly has leading products in the GLP-1 space, with plans to bring pill versions of its weight loss shots to market. Pfizer is playing catch-up...
Analyst ratings
57%
of 28 ratingsMore PFE News
Biontech Se Sponsored Adr (BNTX), Pfizer Inc (PFE) announced an update on their ongoing clinical study. modRNA shingles pursuit from Pfizer and BioNTech now ce...
Key Points There are fears that stocks are overvalued right now, and some data backs this up. This could lead to a market crash, though we can't be certain....
Analyst Geoff Meacham from Citi maintained a Hold rating on Pfizer and keeping the price target at $26.00. Geoff Meacham has given his Hold rating due to a com...
Pfizer Inc ((PFE)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and p...
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 0.19% to 49,316.23 while the NA...
Image source: The Motley Fool. Feb. 3, 2026 at 10:00 a.m. ET Call participants Chairman and Chief Executive Officer — Albert Bourla Chief Scientific Officer —...
Is Pfizer stock a buy at under 9x earnings? Yes. It is. Pfizer (PFE 3.00%) stock gave up 3.3% through 10:50 a.m. ET Tuesday despite delivering an earnings beat...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.